By using peptide-based procedures to inhibit anti-apoptotic proteins like BCL-2, programmed mobile death can be induced in cancer cells, finally resulting in their demise. These specific methodologies exhibit encouraging leads to augmenting the effectiveness of cancer therapy and boosting affected individual results. Clinical trials and preclinical studies are highlighted, displaying https://muqtadaw677jmq9.wikijm.com/user